Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Cambridge Health Alliance | OTHER |
| Concord Hospital | OTHER |
| Fallon Clinic | INDUSTRY |
| Tufts Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR).
We hypothesize that:
We are trying to find out the best way for doctors to talk with their adolescent patients about alcohol and drug use. Adolescents 12-18 who are coming to their doctor's office for a routine well-care or follow-up visit will be invited to participate in the study. Participants do not have to have ever used alcohol or drugs. All participants will answer a computerized questionnaire about alcohol and drug use three times. The first one will be at the time of a doctor's visit. The second time will be three months later and the third time a year later. Adolescents who agree to be in the study during the first year will be in the 'control' group. Their doctor will talk to them about drugs and alcohol the same as he/she usually does for all his/her patients. Those who agree to be in the study during the second year will be in the 'intervention' group. Everyone in the 'intervention' group will receive some advice on the computer about their alcohol and drug use. Their doctor will also give them some specific advice about drug and alcohol use. The researchers have chosen what that advice will be, and all doctors involved in the study will give advice according to the study protocol. Participants and their parents will also be given educational information about alcohol and drugs. We will test the effectiveness of the intervention by comparing drug and alcohol use between those who are in the 'control' group, and those who are in the 'intervention' group.
We we will also validate the Czech version of the CRAFFT screen before conducting the effectiveness trial outlined above in the Czech Republic.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control - New England, USA | No Intervention | Control participants will receive "care as usual" from their provider | |
| cSBA - New England, USA | Experimental | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. |
|
| Control - Prague, CZR | No Intervention | Control participants will receive "care as usual" from their provider | |
| cSBA - Prague, CZR | Experimental | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| cSBA - New England, USA | Behavioral | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. |
| Measure | Description | Time Frame |
|---|---|---|
| Past-90-day Substance Use at 3 Months Among Baseline Substance Users - New England, USA | Among the 12-18 year old primary care patients who reported past-12-month drug or alcohol use at baseline in New England, USA, this analysis reports the number who subsequently reported past-90-day drug or alcohol use at the 3 months post-baseline assessment. | Past-90-days at 3 months post-baseline |
| Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users, New England, USA | Among the 12-18 year old primary care patients who did NOT report past-12-month drug or alcohol use at baseline in New England, USA, this analysis reports the number who subsequently reported past-90-day drug or alcohol use at the 3 months post-baseline assessment. | Past-90-days at 3 months post-baseline |
| Past-12-month Substance Use at 12 Months Among Baseline Substance Users, New England, USA | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA | Past-12-months at 12 months post-baseline |
| Past-12-month Substance Use at 12 Months, Baseline Substance Non-Users, New England, USA | Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA | Past-12-months at 12 months post-baseline |
| Past-90-day Substance Use at 3 Months Among Baseline Substance Users - Prague, CZR | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic |
| Measure | Description | Time Frame |
|---|---|---|
| Any Risky Riding or Driving at 3 Months - New England, USA | Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 3 months post-baseline assessment - New England | Past-90-days at 3 months post-baseline |
| Any Risky Riding or Driving at 12 Months - New England, USA |
Not provided
Inclusion Criteria:
12-18 year old patients coming for well care or follow-up visits to one of the study sites, All levels of substance use, Able to read and understand English
Exclusion Criteria:
Will not be available for 12 month follow-up period, Medically unstable at the time of the visit
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John R Knight, M.D. | Boston Children's Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tufts-New England Medical Center | Boston | Massachusetts | 02111 | United States | ||
| Cambridge Pediatrics |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 10357299 | Background | Knight JR, Shrier LA, Bravender TD, Farrell M, Vander Bilt J, Shaffer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999 Jun;153(6):591-6. doi: 10.1001/archpedi.153.6.591. | |
| 12038895 | Background | Knight JR, Sherritt L, Shrier LA, Harris SK, Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002 Jun;156(6):607-14. doi: 10.1001/archpedi.156.6.607. |
| Label | URL |
|---|---|
| This is the web site of the Center for Adolescent Substance Use and Addiction Research (CeASAR) at Children's Hospital Boston. CeASAR is the research center funded to direct this project. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Quasi-experimental, asynchronous study design with each site as its own control. From 2005 to 2008, 12- to 18-year-olds arriving for routine care at 9 medical offices in New England (n= 2096, 58% females) and 10 in Prague, Czech Republic (n = 589, 47% females) were recruited. Medically/emotionally stable, able to read, and available for follow-ups.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Control - New England | Control participants received "care as usual" from their provider |
| FG001 | cSBA - New England | Computer screen & brief physician advice: Participants in the experimental arm completed a computerized CRAFFT screen and received information on the computer regarding the health effects of substance use. Their provider was given the results of their CRAFFT screen and a list of suggested "talking points" which guided a discussion with the patient about drug and alcohol use. |
| FG002 | Control - Czech Republic | Control participants received "care as usual" from their provider |
| FG003 | cSBA - Czech Republic | Computer screen & brief physician advice: Participants in the experimental arm completed a computerized CRAFFT screen and received information on the computer regarding the health effects of substance use. Their provider was given the results of their CRAFFT screen and a list of suggested "talking points" to guide a discussion with the patient about drug and alcohol use. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-visit Assessment |
|
| ||||||||||||||||||
| Post-visit Checklist |
| |||||||||||||||||||
| 3-months Follow-up |
| |||||||||||||||||||
| 12-months Follow-up |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Control - New England | Control participants will receive "care as usual" from their provider |
| BG001 | Computer Screen & Brief Physician Advice - New England | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. Computer screen & brief physician advice: Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | 7 participants removed due to technical difficulties in Control group; 3 participants removed due to technical difficulties in cSBA intervention group |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Past-90-day Substance Use at 3 Months Among Baseline Substance Users - New England, USA | Among the 12-18 year old primary care patients who reported past-12-month drug or alcohol use at baseline in New England, USA, this analysis reports the number who subsequently reported past-90-day drug or alcohol use at the 3 months post-baseline assessment. | 12-18 year old primary care patients who report past-12-month drug or alcohol use at baseline in New England, USA | Posted | Count of Participants | Participants | Past-90-days at 3 months post-baseline |
|
Through the course of the entire recruitment and follow-up period.
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Control - New England | Control participants will receive "care as usual" from their provider |
Not provided
Not provided
Use of non-randomized, asynchronous study design may have confounded results; 2 NE groups not equivalent in baseline substance use (but controlled for in analysis); self-report and interview-collected data prone to recall and social desirability bias
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Sion Kim Harris, PhD | Boston Children's Hospital - Center for Adolescent Substance Use and Addiction Research | 857-218-4304 | sion.harris@childrens.harvard.edu |
Not provided
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D000437 | Alcoholism |
| ID | Term |
|---|---|
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D019973 | Alcohol-Related Disorders |
Not provided
Not provided
| OTHER |
| University of Vermont | OTHER |
In this before-/after- quasi-experimental trial, all sites first completed a treatment-as-usual phase with assessments only, followed by all sites undergoing training and completing a subsequent intervention phase.
Not provided
Not provided
Not provided
Not provided
|
|
| cSBA - Prague, CZR | Behavioral | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. |
|
|
| Past-90-days at 3 months post-baseline |
| Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users - Prague, CZR | Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic | Past-90-days at 3 months post-baseline |
| Past-12-Month Substance Use at 12 Months Among Baseline Substance Users - Prague, CZR | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic | Past-12-months at 12 months post-baseline |
| Past-12-Month Substance Use at 12 Months Among Baseline Substance Non-Users - Prague, CZR | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic | Past-12-months at 12 months post-baseline |
Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 12 months post-baseline assessment - New England |
| Past-90-days at 12 months post-baseline |
| Any Risky Riding or Driving at 3 Months - Prague, CZR | Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 3 months post-baseline assessment - Prague, Czech Republic | Past-90-days at 3 months post-baseline |
| Any Risky Riding or Driving at 12 Months - Prague, CZR | Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 12 months post-baseline assessment - Prague, Czech Republic | Past-90-days at 12 months post-baseline |
| Cambridge |
| Massachusetts |
| 02139 |
| United States |
| Fallon Clinic | Worcester | Massachusetts | 01605 | United States |
| Capital Region Family Health Center | Concord | New Hampshire | 03301 | United States |
| Milton Family Practice | Milton | Vermont | 05468 | United States |
| Center for the Evaluation, Prevention, and Research of Substance Abuse | Prague | Czechia |
| 17448404 | Background | Van Hook S, Harris SK, Brooks T, Carey P, Kossack R, Kulig J, Knight JR; New England Partnership for Substance Abuse Research. The "Six T's": barriers to screening teens for substance abuse in primary care. J Adolesc Health. 2007 May;40(5):456-61. doi: 10.1016/j.jadohealth.2006.12.007. Epub 2007 Feb 15. |
| 17984404 | Background | Knight JR, Harris SK, Sherritt L, Van Hook S, Lawrence N, Brooks T, Carey P, Kossack R, Kulig J. Prevalence of positive substance abuse screen results among adolescent primary care patients. Arch Pediatr Adolesc Med. 2007 Nov;161(11):1035-41. doi: 10.1001/archpedi.161.11.1035. |
| 18077307 | Background | Knight JR, Harris SK, Sherritt L, Van Hook S, Lawrence N, Brooks T, Carey P, Kossack R, Kulig J. Adolescents' preference for substance abuse screening in primary care practice. Subst Abus. 2007;28(4):107-17. doi: 10.1300/J465v28n04_03. |
| 30079877 | Result | Knight JR, Csemy L, Sherritt L, Starostova O, Van Hook S, Bacic J, Finlay C, Tauber J, Brooks T, Kossack R, Kulig JW, Shaw J, Harris SK. Screening and Brief Advice to Reduce Adolescents' Risk of Riding With Substance-Using Drivers. J Stud Alcohol Drugs. 2018 Jul;79(4):611-616. doi: 10.15288/jsad.2018.79.611. |
| 29054734 | Result | Knight JR, Kuzubova K, Csemy L, Sherritt L, Copelas S, Harris SK. Computer-Facilitated Screening and Brief Advice to Reduce Adolescents' Heavy Episodic Drinking: A Study in Two Countries. J Adolesc Health. 2018 Jan;62(1):118-120. doi: 10.1016/j.jadohealth.2017.08.013. Epub 2017 Oct 17. |
| 28196680 | Result | Hadland SE, Copelas SH, Harris SK. Trajectories of Substance Use Frequency among Adolescents Seen in Primary Care: Implications for Screening. J Pediatr. 2017 May;184:178-185. doi: 10.1016/j.jpeds.2017.01.033. Epub 2017 Feb 10. |
| 27936375 | Result | Harris SK, Johnson JK, Sherritt L, Copelas S, Rappo MA, Wilson CR. Putting Adolescents at Risk: Riding With Drinking Drivers Who Are Adults in the Home. J Stud Alcohol Drugs. 2017 Jan;78(1):146-151. doi: 10.15288/jsad.2017.78.146. |
| 24216313 | Result | Louis-Jacques J, Knight JR, Sherritt L, Van Hook S, Harris SK. Do risky friends change the efficacy of a primary care brief intervention for adolescent alcohol use? J Adolesc Health. 2014 Apr;54(4):449-53. doi: 10.1016/j.jadohealth.2013.09.012. Epub 2013 Nov 8. |
| 22566420 | Result | Harris SK, Csemy L, Sherritt L, Starostova O, Van Hook S, Johnson J, Boulter S, Brooks T, Carey P, Kossack R, Kulig JW, Van Vranken N, Knight JR. Computer-facilitated substance use screening and brief advice for teens in primary care: an international trial. Pediatrics. 2012 Jun;129(6):1072-82. doi: 10.1542/peds.2011-1624. Epub 2012 May 7. |
| 34974918 | Derived | Byregowda H, Flynn AL, Knight JR, Harris SK. Perceived Risk of Harm Mediates the Effects of Primary Care Alcohol Use Screening and Brief Advice in Adolescents. J Adolesc Health. 2022 Mar;70(3):442-449. doi: 10.1016/j.jadohealth.2021.09.029. Epub 2021 Dec 31. |
| 31225897 | Derived | Knight JR, Sherritt L, Gibson EB, Levinson JA, Grubb LK, Samuels RC, Silva T, Vernacchio L, Wornham W, Harris SK. Effect of Computer-Based Substance Use Screening and Brief Behavioral Counseling vs Usual Care for Youths in Pediatric Primary Care: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2019 Jun 5;2(6):e196258. doi: 10.1001/jamanetworkopen.2019.6258. |
| COMPLETED |
|
| NOT COMPLETED |
|
|
| COMPLETED |
|
| NOT COMPLETED |
|
|
| COMPLETED |
|
| NOT COMPLETED |
|
|
| BG002 | Control - Czech Republic | Control participants will receive "care as usual" from their provider |
| BG003 | Computer Screen & Brief Physician Advice - Czech Republic | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. Computer screen & brief physician advice: Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. |
| BG004 | Total | Total of all reporting groups |
| Mean |
| Standard Deviation |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Parents at Home | Number analyzed in three study arm columns for this measure differs from overall number of baseline participants due to missing data on these characteristics for several participants in these arms. | Count of Participants | Participants |
|
| Parents Highest Education Level | Number analyzed in the study arm columns for this measure differs from overall number of baseline participants due to missing data on these characteristics for several participants in these arms. | Count of Participants | Participants |
|
| Visit type | Number analyzed in the study arm columns for this measure differs from overall number of baseline participants due to missing data on these characteristics for several participants in these arms. | Count of Participants | Participants |
|
| Parent Substance Use | Number analyzed in the study arm columns for this measure differs from overall number of baseline participants due to missing data on these characteristics for several participants in these arms. | Count of Participants | Participants |
|
| Sibling Substance Abuse | Count of Participants | Participants |
|
| Peer substance abuse | Number analyzed in the study arm columns for this measure differs from overall number of baseline participants due to missing data on these characteristics for several participants in these arms. | Count of Participants | Participants |
|
Participants in the experimental arm completed the CRAFFT screen on the computer and received information on the computer regarding the health effects of substance use. Their providers were given the results of their CRAFFT screen and a list of suggested "talking points" which they used to guide a discussion with the patient about drug and alcohol use. Participants and their families also received educational brochures about substance use. |
|
|
|
| Primary | Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users, New England, USA | Among the 12-18 year old primary care patients who did NOT report past-12-month drug or alcohol use at baseline in New England, USA, this analysis reports the number who subsequently reported past-90-day drug or alcohol use at the 3 months post-baseline assessment. | 12-18 year old primary care patients who did not report past-12-month drug or alcohol use at baseline in New England, USA | Posted | Count of Participants | Participants | Past-90-days at 3 months post-baseline |
|
|
|
|
| Primary | Past-12-month Substance Use at 12 Months Among Baseline Substance Users, New England, USA | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA | 12-18 year old primary care patients who reported past-12-month drug or alcohol use at baseline in New England, USA | Posted | Count of Participants | Participants | Past-12-months at 12 months post-baseline |
|
|
|
|
| Primary | Past-12-month Substance Use at 12 Months, Baseline Substance Non-Users, New England, USA | Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA | 12-18 year old primary care patients who did not report past-12-month drug or alcohol use at baseline in New England, USA | Posted | Count of Participants | Participants | Past-12-months at 12 months post-baseline |
|
|
|
|
| Primary | Past-90-day Substance Use at 3 Months Among Baseline Substance Users - Prague, CZR | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic | 12-18 year old primary care patients who reported past-12-month drug or alcohol use at baseline in Prague, CZR | Posted | Count of Participants | Participants | Past-90-days at 3 months post-baseline |
|
|
|
|
| Primary | Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users - Prague, CZR | Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic | 12-18 year old primary care patients who did not report past-12-month drug or alcohol use at baseline in Prague, CZR | Posted | Count of Participants | Participants | Past-90-days at 3 months post-baseline |
|
|
|
|
| Primary | Past-12-Month Substance Use at 12 Months Among Baseline Substance Users - Prague, CZR | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic | 12-18 year old primary care patients who reported past-12-month drug or alcohol use at baseline in Prague, CZR | Posted | Count of Participants | Participants | Past-12-months at 12 months post-baseline |
|
|
|
|
| Primary | Past-12-Month Substance Use at 12 Months Among Baseline Substance Non-Users - Prague, CZR | Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic | 12-18 year old primary care patients who did not report past-12-month drug or alcohol use at baseline in Prague, CZR | Posted | Count of Participants | Participants | Past-12-months at 12 months post-baseline |
|
|
|
|
| Secondary | Any Risky Riding or Driving at 3 Months - New England, USA | Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 3 months post-baseline assessment - New England | 12-18 year old primary care patients in New England, USA | Posted | Count of Participants | Participants | Past-90-days at 3 months post-baseline |
|
|
|
|
| Secondary | Any Risky Riding or Driving at 12 Months - New England, USA | Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 12 months post-baseline assessment - New England | 12-18 year old primary care patients in New England, USA | Posted | Count of Participants | Participants | Past-90-days at 12 months post-baseline |
|
|
|
|
| Secondary | Any Risky Riding or Driving at 3 Months - Prague, CZR | Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 3 months post-baseline assessment - Prague, Czech Republic | 12-18 year old primary care patients in Prague, CZR | Posted | Count of Participants | Participants | Past-90-days at 3 months post-baseline |
|
|
|
|
| Secondary | Any Risky Riding or Driving at 12 Months - Prague, CZR | Any past-90-day self-reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs at 12 months post-baseline assessment - Prague, Czech Republic | 12-18 year old primary care patients in Prague, CZR | Posted | Count of Participants | Participants | Past-90-days at 12 months post-baseline |
|
|
|
|
| 0 |
| 1,068 |
| 0 |
| 1,068 |
| EG001 | Computer Screen & Brief Physician Advice - New England | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. Computer screen & brief physician advice: Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. | 0 | 1,028 | 0 | 1,028 |
| EG002 | Control - Czech Republic | Control participants will receive "care as usual" from their provider | 0 | 297 | 0 | 297 |
| EG003 | Computer Screen & Brief Physician Advice - Czech Republic | Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. Computer screen & brief physician advice: Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use. | 0 | 292 | 0 | 292 |
Not provided
Not provided
| Male |
|
|
|
|
|
| One parent or Other |
|
| High school/Secondary school graduate |
|
| Did not complete high school/secondary school |
|
| Don't know |
|
| No |
|
|
|